📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Ducentis Biotherapeutics

1.1 - Company Overview

Ducentis Biotherapeutics Logo

Ducentis Biotherapeutics

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pre-clinical-stage development of novel therapies for inflammation and autoimmune disease, targeting the CD200/CD200R axis to impart deactivating signals to activated immune cells in both innate and adaptive immunity, with potential therapeutic targets including transplant rejection.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Ducentis Biotherapeutics

Arch Oncology Logo

Arch Oncology

HQ: United States Website
  • Description: Provider of venture-stage biopharmaceutical solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arch Oncology company profile →
HS Pharma Logo

HS Pharma

HQ: United States Website
  • Description: Provider of dermatological products for chronic wounds, burns, and drug resistant infections, including a topical ointment sold under the Bensal HP brand. Founded in 2007 and based in Greenville, South Carolina.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HS Pharma company profile →
Cormorant Pharma Logo

Cormorant Pharma

HQ: Sweden Website
  • Description: Provider of biopharmaceutical research and development focused on IL-8's role in malignant tumors, including the HuMax-IL8 program acquired from Genmab A/S. The privately held company is based at the Karolinska Institute Science Park in Stockholm, Sweden.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cormorant Pharma company profile →
Tmunity Therapeutics Logo

Tmunity Therapeutics

HQ: United States Website
  • Description: Provider of engineered T cell therapies and platforms, developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms to unleash the immunological potential of T cells, treat a wide range of disease indications, and enable control over T cell activation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tmunity Therapeutics company profile →
Celyad Oncology Logo

Celyad Oncology

HQ: Belgium Website
  • Description: Provider of cell therapy treatments for severe diseases in immuno-oncology and cardiology, developing CAR T-cell technologies and medical devices. Offers a multispecific CAR approach targeting NKG2D ligands plus another target to address resistance and immune escape, and shRNA multiplexing for non-gene edited CAR T cells. Pipeline includes CAR-T NKR-2, C-Cure, and CYAD-01/02/03.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Celyad Oncology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Ducentis Biotherapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Ducentis Biotherapeutics

2.2 - Growth funds investing in similar companies to Ducentis Biotherapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Ducentis Biotherapeutics

4.2 - Public trading comparable groups for Ducentis Biotherapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Ducentis Biotherapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Ducentis Biotherapeutics

What does Ducentis Biotherapeutics do?

Ducentis Biotherapeutics is a provider of pre-clinical-stage development of novel therapies for inflammation and autoimmune disease, targeting the CD200/CD200R axis to impart deactivating signals to activated immune cells in both innate and adaptive immunity, with potential therapeutic targets including transplant rejection.

Who are Ducentis Biotherapeutics's competitors?

Ducentis Biotherapeutics's competitors and similar companies include Arch Oncology, HS Pharma, Cormorant Pharma, Tmunity Therapeutics, and Celyad Oncology.

Where is Ducentis Biotherapeutics headquartered?

Ducentis Biotherapeutics is headquartered in United Kingdom.

How many employees does Ducentis Biotherapeutics have?

Ducentis Biotherapeutics has 1,000 employees 🔒.

When was Ducentis Biotherapeutics founded?

Ducentis Biotherapeutics was founded in 2010 🔒.

What sector and industry vertical is Ducentis Biotherapeutics in?

Ducentis Biotherapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ducentis Biotherapeutics

Who are the top strategic acquirers in Ducentis Biotherapeutics's sector and industry

Top strategic M&A buyers and acquirers in Ducentis Biotherapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ducentis Biotherapeutics?

Top strategic M&A buyers groups and sectors for Ducentis Biotherapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ducentis Biotherapeutics's sector and industry vertical

Which are the top PE firms investing in Ducentis Biotherapeutics's sector and industry vertical?

Top PE firms investing in Ducentis Biotherapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ducentis Biotherapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ducentis Biotherapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ducentis Biotherapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ducentis Biotherapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ducentis Biotherapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ducentis Biotherapeutics?

The key public trading comparables and valuation benchmarks for Ducentis Biotherapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ducentis Biotherapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ducentis Biotherapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ducentis Biotherapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ducentis Biotherapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ducentis Biotherapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Ducentis Biotherapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Ducentis Biotherapeutics